84.00
-3.00
(-3.45%)
As of 8:00:43 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 10 | 9 |
| Avg. Estimate | 1.92B | 1.83B | 8.23B | 8.65B |
| Low Estimate | 1.77B | 1.67B | 8.01B | 8.36B |
| High Estimate | 2.08B | 1.96B | 8.8B | 9.18B |
| Year Ago Sales | 1.82B | 1.69B | 7.62B | 8.23B |
| Sales Growth (year/est) | 5.62% | 8.21% | 7.94% | 5.12% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AE4.F | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/8/2025 |
| Maintains | UBS: Buy to Buy | 3/21/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/20/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 3/4/2025 |
| Maintains | BMO Capital: Outperform to Outperform | 2/18/2025 |
| Downgrade | Barclays: Overweight to Equal-Weight | 1/27/2025 |